The Role of Mitochondria in Metabolic Syndrome-Associated Cardiomyopathy

Oxid Med Cell Longev. 2022 Jun 23:2022:9196232. doi: 10.1155/2022/9196232. eCollection 2022.

Abstract

With the rapid development of society, the incidence of metabolic syndrome (MS) is increasing rapidly. Evidence indicated that patients diagnosed with MS usually suffered from cardiomyopathy, called metabolic syndrome-associated cardiomyopathy (MSC). The clinical characteristics of MSC included cardiac hypertrophy and diastolic dysfunction, followed by heart failure. Despite many studies on this topic, the detailed mechanisms are not clear yet. As the center of cellular metabolism, mitochondria are crucial for maintaining heart function, while mitochondria dysfunction plays a vital role through mechanisms such as mitochondrial energy deprivation, calcium disorder, and ROS (reactive oxygen species) imbalance during the development of MSC. Accordingly, in this review, we will summarize the characteristics of MSC and especially focus on the mechanisms related to mitochondria. In addition, we will update new therapeutic strategies in this field.

Publication types

  • Review

MeSH terms

  • Cardiomyopathies* / metabolism
  • Heart Failure* / metabolism
  • Humans
  • Metabolic Syndrome* / complications
  • Metabolic Syndrome* / metabolism
  • Mitochondria / metabolism
  • Reactive Oxygen Species / metabolism

Substances

  • Reactive Oxygen Species